RPID vs. ALNT, EYPT, AEHR, QTRX, QSI, NAUT, KEQU, FEIM, SEER, and INTT
Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Allient (ALNT), EyePoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Seer (SEER), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.
Rapid Micro Biosystems vs.
Allient (NASDAQ:ALNT) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings.
Allient has higher revenue and earnings than Rapid Micro Biosystems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks.
Allient has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500.
Allient has a net margin of 2.64% compared to Rapid Micro Biosystems' net margin of -184.93%. Allient's return on equity of 10.80% beat Rapid Micro Biosystems' return on equity.
Allient currently has a consensus target price of $31.00, indicating a potential upside of 29.98%. Rapid Micro Biosystems has a consensus target price of $8.00, indicating a potential upside of 208.88%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Allient.
Allient and Rapid Micro Biosystems both received 6 outperform votes by MarketBeat users. However, 75.00% of users gave Allient an outperform vote while only 35.29% of users gave Rapid Micro Biosystems an outperform vote.
In the previous week, Rapid Micro Biosystems had 10 more articles in the media than Allient. MarketBeat recorded 12 mentions for Rapid Micro Biosystems and 2 mentions for Allient. Allient's average media sentiment score of 0.94 beat Rapid Micro Biosystems' score of 0.21 indicating that Allient is being referred to more favorably in the media.
61.6% of Allient shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 15.6% of Allient shares are held by insiders. Comparatively, 30.4% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Allient beats Rapid Micro Biosystems on 12 of the 17 factors compared between the two stocks.
Get Rapid Micro Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rapid Micro Biosystems Competitors List
Related Companies and Tools
This page (NASDAQ:RPID) was last updated on 3/4/2025 by MarketBeat.com Staff
